Westrock Coffee Company (WEST) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
FY23 net sales were $864.7 million, down 0.4% YoY; Adjusted EBITDA was $45.1 million, down 25% YoY.
The year was a transition period, with legacy operations modernized and the Conway Extract and RTD facility scheduled to deliver its first commercial products in April 2024.
Financial highlights
Q4 net sales were $215.0 million, down 5.6% YoY; gross profit was $34.8 million, including $0.9 million of non-cash mark-to-market losses, versus $34.3 million including $2.7 million of losses in Q4 2022.
Q4 net loss was $20.1 million versus $31.9 million; Q4 operating loss was $6.4 million versus operating income of $1.0 million.
Q4 Adjusted EBITDA was $13.7 million, down $3.7 million YoY.
FY23 gross profit was $139.9 million, including $0.1 million of non-cash mark-to-market gains, versus $152.8 million including $3.5 million of losses in FY22.
FY23 net loss was $34.6 million versus $55.5 million; operating loss was $20.4 million versus operating income of $8.7 million.
Outlook and guidance
FY24 consolidated Adjusted EBITDA guidance is $60 million to $80 million; the broad range reflects the Conway facility startup and customer commercialization ramp.
Actual results may vary materially; forecasted Adjusted EBITDA cannot be reconciled to GAAP net income without unreasonable effort due to uncertain items, including derivative mark-to-market changes and warrant fair-value changes.
Latest events from Westrock Coffee Company
- A $500M shelf offers financing flexibility amid ongoing losses and commodity, supply and execution risks.WEST
Registration filing - Record Q3 EBITDA and refinancing support growth despite weaker sales.WEST
Q3 2026 - Q2 net sales up 8.8%, Adjusted EBITDA up 38.9%, and 2026 EBITDA guidance reaffirmed.WEST
Q2 2026 - Directors and auditor ratified with overwhelming support; no stockholder questions raised.WEST
AGM 2026 - Net sales up 44.4%, Adjusted EBITDA tripled, and Conway facility fully commercialized.WEST
Q1 2026 - Election of four directors and auditor ratification headline the 2026 virtual annual meeting.WEST
Proxy filing - Virtual 2026 meeting to elect directors, ratify auditor, and highlight strong governance and performance.WEST
Proxy filing - 2025 net sales up 39.8% to $1.2B, with record EBITDA and strong 2026 growth outlook.WEST
Q4 2025 - Gross margin and EBITDA rose as Conway ramped, with 2024 guidance narrowed and 2025 outlook strong.WEST
Q2 2024